When Digital Biomarkers Drift: A Critical Review of Temporal, Technological, Behavioral, and Population Instability in AI Models for Neurodegenerative Disease

Digital biomarkers derived from smartphones, wearables, and connected sensors are increasingly combined with artificial intelligence (AI) to detect and monitor neurodegenerative diseases, yet the signals on which these models depend are not static. This critical review, based on a structured search of biomedical, engineering, and regulatory literature, examines four interacting sources of instability: temporal drift arising from disease progression, aging, treatment, and symptom fluctuation; technological drift caused by changes in devices, sensors, software, and processing pipelines; behavioral and contextual drift associated with routines, adherence, engagement, and missing data; and population drift that arises when deployment cohorts differ from narrow development cohorts. We map these sources onto established machine-learning concepts, including covariate shift, label shift, and concept drift, and summarize disease- and modality-specific evidence in Parkinson disease, Alzheimer disease, Huntington disease, and related conditions. Across the literature, separating genuine disease progression from measurement-related, behavioral, and population-related change remains difficult, and validation based on random data splits, short follow-up, homogeneous cohorts, and single devices can overestimate durability. These limitations can produce false deterioration signals, unstable individual predictions, and inequitable performance after deployment. We propose a Detect → Attribute → Quantify → Adapt → Validate → Monitor (DAQAV-M) framework with illustrative operational criteria, attribution strategies, and version-controlled updating rules, and we position it relative to existing dataset-shift, model-monitoring, and regulatory lifecycle approaches. Trustworthy digital biomarkers require lifecycle validation that separates biomarker validity from model performance and tests stability within individuals, across technologies, and across diverse populations.

Authors

Institutions

Publication Details

Journal
Neuroscience Research and Clinical Practice
Published
2026-11-16
DOI
https://doi.org/10.64229/8m5kv497
Primary Topic
Artificial Intelligence in Healthcare and Education
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

When Digital Biomarkers Drift: A Critical Review of Temporal, Technological, Behavioral, and Population Instability in AI Models for Neurodegenerative Disease

Abdul-Basid Yakubu, Olaitan Ebenezer Oluwadare, Faith Uzochi Sunday, Anyebe Daniel Ameh
Neuroscience Research and Clinical Practice
Artificial Intelligence in Healthcare and Education
article

When Digital Biomarkers Drift: A Critical Review of Temporal, Technological, Behavioral, and Population Instability in AI Models for Neurodegenerative Disease

Abdul-Basid Yakubu, Olaitan Ebenezer Oluwadare, Faith Uzochi Sunday, Anyebe Daniel Ameh
article en

Abstract

Digital biomarkers derived from smartphones, wearables, and connected sensors are increasingly combined with artificial intelligence (AI) to detect and monitor neurodegenerative diseases, yet the signals on which these models depend are not static. This critical review, based on a structured search of biomedical, engineering, and regulatory literature, examines four interacting sources of instability: temporal drift arising from disease progression, aging, treatment, and symptom fluctuation; technological drift caused by changes in devices, sensors, software, and processing pipelines; behavioral and contextual drift associated with routines, adherence, engagement, and missing data; and population drift that arises when deployment cohorts differ from narrow development cohorts. We map these sources onto established machine-learning concepts, including covariate shift, label shift, and concept drift, and summarize disease- and modality-specific evidence in Parkinson disease, Alzheimer disease, Huntington disease, and related conditions. Across the literature, separating genuine disease progression from measurement-related, behavioral, and population-related change remains difficult, and validation based on random data splits, short follow-up, homogeneous cohorts, and single devices can overestimate durability. These limitations can produce false deterioration signals, unstable individual predictions, and inequitable performance after deployment. We propose a Detect → Attribute → Quantify → Adapt → Validate → Monitor (DAQAV-M) framework with illustrative operational criteria, attribution strategies, and version-controlled updating rules, and we position it relative to existing dataset-shift, model-monitoring, and regulatory lifecycle approaches. Trustworthy digital biomarkers require lifecycle validation that separates biomarker validity from model performance and tests stability within individuals, across technologies, and across diverse populations.

Neuroscience Research and Clinical PracticeVol. 2(2)
Delaware State University (US), University of Denver (US), University of Chester (GB)
Artificial Intelligence in Healthcare and Education
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon